242 related articles for article (PubMed ID: 25204619)
1. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
3. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
[TBL] [Abstract][Full Text] [Related]
4. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.
Whitaker LH; Murray AA; Matthews R; Shaw G; Williams AR; Saunders PT; Critchley HO
Hum Reprod; 2017 Mar; 32(3):531-543. PubMed ID: 28130434
[TBL] [Abstract][Full Text] [Related]
5. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
6. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
Dey R; Roychowdhury P
J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
[TBL] [Abstract][Full Text] [Related]
7. Structural and evolutionary analysis of the co-activator binding domain in vertebrate progesterone receptors.
Kattoula SR; Baker ME
J Steroid Biochem Mol Biol; 2014 May; 141():7-15. PubMed ID: 24388949
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor profiling of vinclozolin and its primary metabolites.
Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
[TBL] [Abstract][Full Text] [Related]
9. The evolution of mineralocorticoid receptors.
Hu X; Funder JW
Mol Endocrinol; 2006 Jul; 20(7):1471-8. PubMed ID: 16195247
[TBL] [Abstract][Full Text] [Related]
10. Ulipristal acetate does not impact human normal breast tissue.
Communal L; Vilasco M; Hugon-Rodin J; Courtin A; Mourra N; Lahlou N; Dumont S; Chaouat M; Forgez P; Gompel A
Hum Reprod; 2012 Sep; 27(9):2785-98. PubMed ID: 22740493
[TBL] [Abstract][Full Text] [Related]
11. The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation.
Raaijmakers HC; Versteegh JE; Uitdehaag JC
J Biol Chem; 2009 Jul; 284(29):19572-9. PubMed ID: 19372222
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of spirolactone recognition by the mineralocorticoid receptor.
Huyet J; Pinon GM; Fay MR; Fagart J; Rafestin-Oblin ME
Mol Pharmacol; 2007 Sep; 72(3):563-71. PubMed ID: 17569793
[TBL] [Abstract][Full Text] [Related]
13. Detection and functional portrayal of a novel class of dihydrotestosterone derived selective progesterone receptor modulators (SPRM).
Andrieu T; Mani O; Goepfert C; Bertolini R; Guettinger A; Setoud R; Uh KY; Baker ME; Frey FJ; Frey BM
J Steroid Biochem Mol Biol; 2015 Mar; 147():111-23. PubMed ID: 25541437
[TBL] [Abstract][Full Text] [Related]
14. Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists.
Lin HR
Bioorg Med Chem Lett; 2014 Aug; 24(15):3626-32. PubMed ID: 24915879
[TBL] [Abstract][Full Text] [Related]
15. A new strategy for selective targeting of progesterone receptor with passive antagonists.
Khan JA; Tikad A; Fay M; Hamze A; Fagart J; Chabbert-Buffet N; Meduri G; Amazit L; Brion JD; Alami M; Lombès M; Loosfelt H; Rafestin-Oblin ME
Mol Endocrinol; 2013 Jun; 27(6):909-24. PubMed ID: 23579486
[TBL] [Abstract][Full Text] [Related]
16. Ulipristal Acetate Antagonizes the Inhibitory Effect of Progesterone on Ciliary Beat Frequency and Upregulates Steroid Receptor Expression Levels in Human Fallopian Tubes.
Yuan J; Zhao W; Yan M; Zhu Q; Qin G; Qiu J; Zhang J
Reprod Sci; 2015 Dec; 22(12):1516-23. PubMed ID: 26045548
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
Kannan A; Bhurke A; Sitruk-Ware R; Lalitkumar PG; Gemzell-Danielsson K; Williams ARW; Taylor RN; Bagchi MK; Bagchi IC
Reprod Sci; 2018 Mar; 25(3):320-328. PubMed ID: 29241443
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment.
Melis GB; Piras B; Marotto MF; Orru' MM; Maricosu G; Pilloni M; Guerriero S; Angiolucci M; Lello S; Paoletti AM
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):901-8. PubMed ID: 22681335
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease.
Jiménez-Panizo A; Pérez P; Rojas AM; Fuentes-Prior P; Estébanez-Perpiñá E
Endocr Relat Cancer; 2019 Aug; 26(8):R479-R497. PubMed ID: 31252411
[TBL] [Abstract][Full Text] [Related]
20. Atomic structure of progesterone complexed with its receptor.
Williams SP; Sigler PB
Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]